Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition
Published version of a preprint
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
The CRL4 CRBN E3 ubiquitin ligase is the target of molecular glue degrader compounds that reprogram ligase specificity to induce the degradation of clinically relevant neosubstrate proteins. Known cereblon (CRBN) neosubstrates share a generalizable β-hairpin G-loop recognition motif that allows for the systematic exploration of the CRBN target space. Computational mining approaches using structure- and surface-based matchmaking algorithms predict more than 1600 CRBN-compatible G-loop proteins across the human proteome, including the newly discovered helical G-loop motif, and identify the noncanonical neosubstrate binding mode of VAV1 that engages CRBN through a molecular surface mimicry mechanism. This work broadens the CRBN target space, redefines rules for neosubstrate recognition, and establishes a platform for the elimination of challenging drug targets by repurposing CRL4 CRBN through next-generation molecular glue degraders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The compound-mediated interface between CRBN and KAT2ANTD not only lacks a G-loop structural motif but also does not contain a structural mimic of the canonical motif as seen in VAV1 (11).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“We found that KAT2ANTD buries a substantial portion of both the CRBNNTD and CRBNCTD, forming a broad PPI that is distinct from the more hotspot-driven interfaces created by the G-loop neo-substrates (e.g., IKZF1(45), GSPT1(40)), the G-loop mimetic (VAV1(11)), and the non-G-loop (G3BP2(14)) (Fig 3F).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“together these results show that the targetable universe of proteins degradable by CRBN-recruiting MGs is not limited to POIs that contain the G-loop degron motif (4), or its structural mimic (11).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“While targets with G-loop-like motifs have only sampled a fraction of this PPI hotspot on the CRBN CULT domain25 (Fig. 5), the G3BP2 binding mode demonstrates how engagement of a separate region of the hotspot bypasses previous requirements for target engagement.”
From Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry (2026) · cites this paper as [25]
In the citing paper
“Strikingly, G3BP2 lacks key contacts with the CRBN CULT domain commonly involved in neosubstrate recruitment25–28, which distinguishes the binding mode of G3BP2 from other structurally characterized CRBN targets (Fig. 5a–d and Extended Data Fig. 10).”
From Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry (2026) · cites this paper as [25]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
ColabFold - Making protein folding accessible to all
Mirdita, M., Schütze, K., Moriwaki, Y., Heo, L., Ovchinnikov, S., & Steinegger, M. (2021) · doi:10.1101/2021.08.15.456425 · Cited by 9,391
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
Pfam: The protein families database in 2021
Mistry, J., Chuguransky, S., Williams, L., Qureshi, M., Salazar, G. A., Sonnhammer, E. L. L., Tosatto, S. C. E., Paladin, L., Raj, S., Richardson, L. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa913 · Cited by 7,452
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Improvements to the APBS biomolecular solvation software suite
Jurrus, E., Engel, D., Star, K., Monson, K., Brandi, J., Felberg, L. E., Brookes, D. H., Wilson, L., Chen, J., Liles, K., et al. (2018) · Protein Science · doi:10.1002/pro.3280 · Cited by 2,405
Paysan-Lafosse, T., Blum, M., Chuguransky, S., Grego, T., Pinto, B. L., Salazar, G. A., Bileschi, M. L., Bork, P., Bridge, A., Colwell, L., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac993 · Cited by 2,399
Research works printed but not linked: 1
- O. S. Smart, G. Bricogne, Multifaceted Roles of Crystallography in Modern Drug Discovery, NATO Science for Peace and Security Series (Springer, 2015), pp. 165–181.
Cited by
Unveiling the hidden interactome of CRBN molecular glues
Baek, K., Metivier, R. J., Burman, S. S. R., Bushman, J. W., Yoon, H., Lumpkin, R. J., Ryan, J. K., Abeja, D. M., Lakshminarayan, M., Yue, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62099-w · Cited by 89
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics
Steger, M., Nishiguchi, G., Wu, Q., Schwalb, B., Shashikadze, B., McGowan, K., Actis, M., Aggarwal, A., Shi, Z., Price, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62829-0 · Cited by 32
High-throughput ligand diversification to discover chemical inducers of proximity
Shaum, J. B., Ordoño, M. M. I., Steen, E. A., Wenge, D. V., Cheong, H., Janowski, J., Hunkeler, M., Bilotta, E. M., Rutter, Z. J., Barta, P. A., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02137-2 · Cited by 45
“…indicate that CRBN makes concerted movements to accommodate the induced ENL interaction with a high degree of shape complementarity, which is congruent with emerging studies demonstrating that the CRBN surface is highly plastic and capable of accommodating diverse structural degrons 42,104–106 .”
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
Sylvain, A., Stoehr, N., Ma, F., Cernijenko, A., Schröder, M., Khoshouei, M., Vogelsanger, M., Schoenboerner, M., Burke, A., Rao, P., et al. (2025) · Cell Chemical Biology · doi:10.1016/j.chembiol.2025.06.005 · Cited by 23
Machine learning to predict de novo protein–protein interactions
Gaínza, P., Bunker, R. D., Townson, S. A., & Castle, J. C. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.04.013 · Cited by 27
Self-citationLeveraging Structural and Computational Biology for Molecular Glue Discovery
Kang, C., & Xu, W. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00076 · Cited by 23
Primed for degradation: How weak protein interactions enable molecular glue degraders
Hanzl, A., Inghelram, C., Schmitt, S., & Thomä, N. H. (2025) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2025.103052 · Cited by 17
Exploring nondegrading molecular glues for protein–protein interactions
Yu, S., Zhou, L., Yang, J., Zhang, J., & Lu, W. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.07.005 · Cited by 22
Benchmarking Cofolding Methods for Molecular Glue Ternary Structure Prediction
Liao, Y., Zhu, J., Xie, J., Lai, L., & Pei, J. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01860 · Cited by 27
Xu, Y., Zhao, W., Nie, H., Wang, J., Fu, J., Hu, H., Liu, Z., Tao, S., Zhang, M., Zhou, Y., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505053 · Cited by 17
MolGlueDB: an online database of molecular glues
Wang, X., Zhuang, Z., Zhang, C., Zhang, B., Zhan, W., Wang, Y., Liu, Z., Yuan, S., Niu, W., He, Q., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf811 · Cited by 22
“However, MGDs still face several challenges in therapeutic development [ 3 , 41–43 ].”
Cai, P., Disraeli, C., Sauter, B., Zhanybekova, S., & Gillingham, D. G. (2025) · Chemical Science · doi:10.1039/d5sc01251a · Cited by 15
Proteome-Wide Discovery of Degradable Proteins Using Bifunctional Molecules
Forrest, I., Conway, L. P., Gathmann, C., Jadhav, A. M., Chiu, T.-Y., Chaheine, C. M., Estrada, M. A., Shrestha, A., Sarris, K., Reitsma, J. M., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c01594 · Cited by 14
Izaguirre, J. A., McDargh, Z. A., Trovato, F., Wu, Y., Palpant, T., Razavi, A. M., Koh, C. M., & Xu, H. (2025) · Research Square · doi:10.1101/2025.01.13.632817 · Cited by 12
Identification of an allosteric site on the E3 ligase adapter cereblon
Dippon, V. N., Rizvi, Z., Choudhry, A. E., Chung, C.-W., Alkuraya, I. F., Xu, W., Tao, X. B., Jurewicz, A. J., Schneck, J. L., Chen, W., et al. (2026) · Nature · doi:10.1038/s41586-025-09994-w · Cited by 14
From serendipity to strategy: molecular glue degraders in cancer therapeutics
Darling, S., Bajrami, I., & West, S. C. (2025) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2025.2564068 · Cited by 9
“From these additional screens two distinct new classes of cRBN degron were uncovered: “helical g-loops” and “surface mimics”, the latter being particularly intriguing as they lack the eponymous glycine thought to be essential in cRBN recruitment (Petzold et al. 2025).”
InfluentialOpportunities in proximity modulation: Bridging academia and industry
Đikić, I., Mayor‐Ruiz, C., Winter, G. E., Koch, K., Ciulli, A., & Thomä, N. H. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.07.018 · Cited by 11
“94 AI/machine learning (ML)-driven platforms are being increasingly applied to drug design and are thus expected to have a significant impact on the fields of TPD and proximity induction as well.”
Che, X., & The Statistical Mechanics Inference Team (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.23.630090 · Cited by 10
Rational discovery of molecular glue degraders based on block chemistry
Wei, J., Feng, W., Chen, Q., Li, Q., & Chen, Z. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104480 · Cited by 12
MGTbind: a comprehensive database of molecular glue ternary interactome
Zhu, J., Liao, Y., Lin, H., Xie, J., Deng, Z., Han, J., Zhang, Z., Xiao, J., Wang, Z., Zhang, S., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1075 · Cited by 13
Ba, X., Dehghany, M., Mortensen, D. S., & Holmberg‐Douglas, N. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00886g · Cited by 10
Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry
Annunziato, S., Quan, C., Donckele, E. J., Lamberto, I., Bunker, R. D., Zlotosch, M., Schwander, L., Murthy, A., Wiedmer, L., Staehly, C., et al. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01738-8 · Cited by 9
“…G-loop-independent target VAV1 was shown to engage CRBN through surface features that resemble the GSPT1 degron, a well-established CRBN neosubstrate, demonstrating that target compatibility with CRBN depends on surface complementarity rather than the presence of conserved structural motifs 25 .”
InfluentialSelf-citationDegrons and degradation signals beyond short linear motifs
Wang, B., & Zheng, N. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-02056-2 · Cited by 10
“Alternatively, structural insights from the mechanism of action of existing MGDs can be leveraged to expand the target space, as seen in the recent identification of glueable CRBN neosubstrates without a canonical G-loop degron 144 .”
A degron-mimicking molecular glue drives CRBN homo-dimerization and degradation
Langousis, G., Gaínza, P., Hunkeler, M., Kapsitidou, D., Donckèle, E. J., Annunziato, S., Wiedmer, L., Jones, K. F. M., DeMarco, B., Quan, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65094-3 · Cited by 13
Self-citationTargeted degradation of GSPT1 and NEK7 by a molecular glue prodrug for treatment of HCC
Glaza, P., Pluta, R., Odrzywol, K., Klejnot, M., Wieczorek, M., Cottens, S., Coppen, D., Dobrzański, P., Drmota, T., Lis-Grześniak, J., et al. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01641-9 · Cited by 10
Targeted protein degradation in autoimmune diseases: from mechanisms to therapeutic breakthroughs
Song, Y., Zhou, B., Long, J., & Peng, Y. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103475 · Cited by 9
Huber, A. D., Lin, W., Jung, K., Poudel, S., Yang, G., Wu, J., Carrigan, A., Pagala, V., Wang, W., Fu, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64773-5 · Cited by 7
Targeting Non-BET Bromodomains: Emerging Opportunities in Drug Discovery
Li, H., Jiang, F., Sun, Q., Huang, J., Chen, X., He, D., & Shen, X. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01162 · Cited by 5
Fabrication and Properties of Hard Coatings by a Hybrid PVD Method
Zhang, R., Wang, Q., Xu, Y. X., et al. (2025) · Lubricants · doi:10.3390/lubricants13090390 · Cited by 5
The rise of AlphaFold in drug design
Stecuła, A., Paul, R., Litchfield, K., Dalton, S. E., Low, C. M. R., Reis, C. R., & Congreve, M. (2025) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2025.09.002 · Cited by 7
Gray, J. L., Xiao, Z., Rogga, V. V., Zhang, X., & Tate, E. W. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c12299 · Cited by 6
Comparative assessment of co-folding methods for molecular glue ternary structure predictionPreprint
Liao, Y., Zhu, J., Xie, J., Lai, L., & Pei, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.25.655997 · Cited by 4
Lin, H., Yu, X. F., Zheng, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.08.658535 · Cited by 4
Huang, K., Luo, P., Li, C., Huang, N., Yao, K., Lan, X.-X., Du, L.-F., Miao, Y., Tang, Q. H., Xu, Y., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118387 · Cited by 4
Diversified design strategies for small-molecule PROTACs: How do we select?
Chen, Q., & Liang, J.-H. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118593 · Cited by 5
Zhang, Y., Li, L., Xu, J., Che, C.-C., Jia, J., Lu, H., You, Q., & Xu, X. (2026) · Molecules · doi:10.3390/molecules31030459 · Cited by 5
“For instance, VAV1 binds to CRBN through a molecular surface mimicry mechanism (Figure 9) [128].”
Park, B., & Lehn, R. C. V. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02566 · Cited by 4
Molecular glue degraders: Rational design, specificity engineering, and advanced delivery
Ma, L., Wang, N., Zhu, J., Wu, L., He, S., & Zhang, B. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.02.020 · Cited by 8
“Repre-sentative helical G-loop candidates included the FKBP12-rapamycin binding (FRB) domain of mTOR and SRC-family kinases such as HCK, BLK, LCK, and LYN, highlighting that CRBN-compatible, G-loop-like backbone presentation can arise in both ß -hairpin and helical contexts 25 .”
InfluentialXu, Y., Zhao, W., Fu, J., Liu, Z., Nie, H., Zhang, J., Guo, J., Tan, M., & Chen, X. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c22099 · Cited by 6
Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications
Knoll, N., Neamati, N., & Üren, A. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00730 · Cited by 7
Safety considerations for cereblon-recruiting targeted protein degraders
Garside, H., Aslamkhan, A. G., Daniels, D. L., Datta, K., Pedersen, M. E., Hukkanen, R. R., Jones, L. H., Ketter, N., Lahoti, T. S., Loberg, L. I., et al. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01426-2 · Cited by 11
Methods to Study the Molecular Mechanism and Drive the Design of Protein Degraders
Crowe, C., & Ciulli, A. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00800 · Cited by 6
Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues
Ojeda, S., Wang, M., Baek, K., Bourgeois, W., Sommerschield, A., Yue, H., Metivier, R. J., Karagiannis, P., Levitz, T. S., Xiong, Y., et al. (2026) · Science · doi:10.1126/science.aef5391 · Cited by 5
Metabolite glues as a means of purine sensing and chemotherapeutic response
Witus, S. R., Kober, M. M., Roh, H., Yang, Z., Choueiry, F., Ghate, A. S., Titov, D. V., & Rapé, M. (2026) · Nature · doi:10.1038/s41586-026-10790-3 · Cited by 8
“The binding of molecular glues at the interface of two proteins complicates efforts to improve the potency of therapeutic compounds, and previous work has shown that chemical modification of molecular glues can in fact rewire the composition of stabilized protein complexes 41,42 .”
Xu, Y., Zhao, W., Nie, H., Wang, J., Fu, J., Hu, H., Liu, Z., Tao, S., Zhang, M., Zhou, Y., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202505053 · Cited by 4
Rosignoli, S., Giordani, S., Pacelli, M., Guarguaglini, G., & Paiardini, A. (2025) · Biomolecules · doi:10.3390/biom15020206 · Cited by 2
ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders
Kazi, R. S., Bailey, H., Gerhartz, J., Shah, V. J., Toker, B., Bein, J., Wild, P. J., Nowak, R. P., Mosler, T., & Đikić, I. (2026) · Disease and Therapeutics · doi:10.1016/j.dist.2026.100004 · Cited by 4
Rudolph, J., Hoeflich, K. P., & Dar, A. C. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01411-9 · Cited by 13
“A recent proteome-scale survey predicted approximately 1,400 human proteins with compatible G-loop-like motifs, many of which are kinases, which helps to explain the expanding set of kinase substrates for CRBN glues 130 .”
TRI-611, a selective, brain-penetrant molecular glue degrader of ALK
Conery, A. R., La, D. S., Alekseyenko, A. A., Marcoux, D., Bart, A. G., Harlow, M. L., Arsenault, P. R., Cantone, N. R., Casaubon, R. L., Constan, A., et al. (2026) · Nature · doi:10.1038/s41586-026-10998-3 · Cited by 7
“…knowledge the first clinical-stage MGD of an oncogenic fusion protein and highlights a previously undescribed degron element for CRBN recognition that expands on a recent publication highlighting CRBN recruitment motifs 29 and supports a paradigm shift in the field of targeted protein degradation.”
Emerging opportunities in the rewiring of biology through proximity inducing small molecules
Hann, M. M. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00608b · Cited by 3
Developing potent and selective TBK1 molecular glue degraders for cancer immunotherapyPreprint
Caldwell, J. J., Zanon, P. R. A., Ferguson, I., Hallett, S. T., Tenev, T., Serrano-Aparicio, N., Wood, R. J. H., Khan, S., John, S. W., Wilson, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702304 · Cited by 3
PROTACs and Glues: Striking Perspectives for Engineering Cancer Therapy À La Carte
Ferrero, J.-M., Gal, J., Mograbi, B., & Milano, G. A. (2025) · Pharmaceuticals · doi:10.3390/ph18091397 · Cited by 3
“A key example of this potential is provided by Petzold et al., who computationally identified over 1400 Cereblon immunomodulatory drugs (CRBN–IMiD) compatible neosubstrates, thereby considerably reshaping existing paradigms of substrate recognition [32].”
Liu, T., Ma, J., Dong, G., Zhang, M., Song, S., Zhang, X., Qi, S., Cheng, M., Liu, W., Wang, X., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118180 · Cited by 1
A DRUG HUNTER’S APPROACH TO MOLECULAR GLUES
La, D. S., Nasveschuk, C. G., & Gilbert, A. M. (2025) · Medicinal chemistry reviews · doi:10.1021/mc-2025-vol60.ch16 · Cited by 1
Clues for glues: from serendipity to nature’s blueprints in degrader discovery
Kozicka, Z. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253058 · Cited by 6
Understanding the Role of H-Bonds in the Stability of Molecular Glue-Induced Ternary Complexes
Blanco-Gabella, P., Ivanova, V., Serrano‐Morrás, Á., Fuchs, J. E., & Juárez‐Jiménez, J. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02718 · Cited by 2
GlueFinder: A Data-Driven Framework for the Rational Discovery of Molecular Glues
Skolnick, J., Srinivasan, B., & Zhou, H. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c03232 · Cited by 3
Won, H.-J., Baek, S. M., Lee, M. H., Park, J. H., Shin, J., Yang, Y., Jang, Y. H., Inn, K., & Kim, N. (2026) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202501208 · Cited by 3
Target discovery and drug design in the era of artificial intelligence
Fleming, P., & Ivanov, A. A. (2026) · Medicinal Chemistry Research · doi:10.1007/s00044-026-03562-1 · Cited by 5
Wang, J., Yin, G., Chi, Y., Feng, Y., Zhou, C., Nie, H., Zhang, Z., Meng, S., Chen, Y., Zhou, Z., et al. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.3518516 · Cited by 2
Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021–2025)
Wang, Y., Wang, C., Ren, F., et al. (2026) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2026.2674071 · Cited by 1
“An attractive alternative worth pursuing in five or 10 years is a PKMYT1 molecular glue featuring lower molecular weight, enhanced cell permeability, improved oral absorption, and superior drug-like properties [113,114].”
The molecular basis for nuclear pore destruction by a proximity-inducing molecular glue
Hinshaw, S. M., Yuan, L., Noman, M. A. A., Martinez, M. J., Colombo, G. M., Dwyer, B. G., Ji, W., Romero, B. A., Forrest, I., Lu, J., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.04.016 · Cited by 2
Yoshimura, S., Actis, M., Seffernick, J. T., McGrath, L., Jarusiewicz, J., Aggarwal, A., Li, A., Li, Y., Lee, D. G., Yang, L., et al. (2026) · Blood · doi:10.1182/blood.2025031127 · Cited by 4
Proteomics‐Driven Strategies for Proximity‐Inducing Drug Discovery
Fan, R., Ni, J., Zhou, T., Jiang, H. Q., Zhao, W., & Tan, M. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.3307512 · Cited by 1
A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition
Kim, J. H., Mills, C. E., Kozicka, Z., Scott, D. C., Jin, C., Jiang, Z., Dwyer, B. G., Geng, Q., Toenjes, S. T., Byun, W. S., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c10277 · Cited by 2
Liu, Y., Chen, L., Peng, B., Zeng, P., Cao, L., Huang, L., Zhou, L., Yang, S., Wang, J., Sun, Y., et al. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.1973691 · Cited by 2
Proteome-wide identification of the druggable CRBN interactome
Galli, P., Xiao, S., Meng, Y., Hanzl, A., Bendel, A. M., Baur, R., Aguirre, J. D., Díaz-Rovira, A. M., Stammnitz, M. R., Kempf, G., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03237-7 · Cited by 3
Lin, H., Yang, Y.-Y., Maity, S., Sun, Q., & Wang, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.18.683219 · Cited by 1
Identification and SAR optimization of FBXO22-mediated TEAD Targeted Glue™ degradersPreprint
Fisher, M., Fletcher, A., Hamby, C., Miles, J., Ambler, M., Azevedo, A., Bisetto, S., Davies, C. T. R., Drouhin, P., Greger, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.21.719895 · Cited by 1
Targeted degradation of GSPT1 and NEK7 by a molecular glue prodrug for treatment of HCCPreprint
Glaza, P., Pluta, R., Odrzywół, K. E., Klejnot, M., Wieczorek, M., Cottens, S., Coppen, D., Dobrzański, P., Drmota, T., Lis-Grześniak, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.25.661504
Broader horizons for cereblon glue degraders
Eccleston, A. (2025) · Nature Reviews Drug Discovery · doi:10.1038/d41573-025-00133-8
Sticky business: Rationalizing CRBN’s zinc-finger targeting by molecular glues
Bushman, J. W., & Potts, P. R. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.07.022
Systematic molecular glue drug discovery with a high-throughput effector protein remodeling platformPreprint
Lu, J., Stuart, K., Teague, R., Tarry, C., Yan, R., Morgan, T., Nock, E., Mulhearn, D. S., Jones, M., Knaggs, M. H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.17.664724
Progress on molecular glue degraders
Chen, J., Deng, Z., Li, H., & Liu, L. (2025) · Scientia Sinica Chimica · doi:10.1360/ssc-2025-0228
Computational approaches enhance the design of molecular glue degraders for undruggable proteins
Deshani, S. G. M. A., Madushani, G. R. D. S., Karunaratne, V., Vinit, K., & Hao, G. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104577 · Cited by 2
Mapping the latent CRBN-molecular glue degrader interactomePreprint
Galli, P., Xiao, S., Meng, Y., Hanzl, A., Bendel, A. M., Aguirre, J. D., Díaz-Rovira, A. M., Stammnitz, M. R., Kempf, G., Kater, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.02.691773
Michon, M., Curpanen, S., Pessey, O., Thaï, R., Gaillard, J., Herbette, G., Hinsinger, K., Gillet, D., Armengaud, J., Cintrat, J., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118645
Adamska, A., Chahin, H., Muciño-Olmos, E. A., Esfandyari, J., Aaltonen, K. E., Granados-Aparici, S., Siaw, J. T., Radke, K., Lago, C., Pasikowski, P., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03647-0
“The MG-mediated degradability of 25 potential CRBN off-targets was assessed using a recently described bioinformatics approach [29], with tool validity first confirmed by verifying the presence of the G-loop motif in GSPT1, GSPT2, SALL4, CK1α, and IKZF1.”
Disrupting linearity of PROTAC scaffolds prevents off-target complex I inhibitionPreprint
Richert, N., Nůsková, H., Samarin, J., Ivanov, B. S., Saoud, M., Deis, F. H., de Vries, N., Sievers, S., Poschet, G., Ziegler, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.13.702718
Molecular Glue Degraders Redefining Targeted Therapies From Discovery to Therapeutic Applications
Wen, J., Yu, J., Wen, W., & Jiang, B. (2026) · MedComm – Oncology · doi:10.1002/mog2.70058
Wang, J., Lin, H., Yu, X., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-6712113/v1
Nie, H., Wang, J., Xu, H., Zhou, Y.-J., Yin, G., Xu, X., Xu, G., Chen, B., Li, X., Hu, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.16.712139
Halofuginone is a Molecular Glue Degrader of Integrin β 4
Gong, W., Yang, D., Tian, J., Chai, Y., Yu, T., Wu, Q., Wang, Y., Zhang, W., & Zhan, Q. (2026) · Advanced Science · doi:10.1002/advs.202515970
Medicinal chemistry enabling advances in protein structure prediction
Munasinghe, A., Zhang, Z., & Wu, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00096-0
Carcinogenicity Risk Assessment of Targeted Protein Degraders
Sidaway, J. E., & Meseck, E. K. (2026) · Toxicologic Pathology · doi:10.1177/01926233261439117
Lin, H., Yang, Y., Maity, S., Sun, Q., & Wang, J. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c01023 · Cited by 2
Metabolic glues as a means of purine sensing and chemotherapeutic responsePreprint
Witus, S. R., Kober, M. M., Roh, H., Yang, Z., Choueiry, F., Ghate, A. S., Titov, D. V., & Rapé, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.05.723063
Wang, J., Yin, G., Chi, Y., Feng, Y., Zhou, C., Nie, H., Zhang, Z., Meng, S., Chen, Y., Zhou, Z., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.3518516
Ratiometric transcriptional activation by protein degradation
Gray, M. A., Randal, K. L., Co, J., Tang, M. T., Xue, A., Chen, S. W., Razumkov, H., Omran, Q. Q., Solow-Cordero, D. E., Yu, J., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.009
Piercing myeloma’s Achilles’ heel
Wang, E. S. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02219-9
Cao, X., Huang, X., Song, C., Shi, S., Zhu, Y., Zheng, L., Liang, G., & Chen, L. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119034
Proteomics‐Driven Strategies for Proximity‐Inducing Drug Discovery
Fan, R., Ni, J., Zhou, T., Jiang, H. Q., Zhao, W., & Tan, M. (2026) · Angewandte Chemie · doi:10.1002/ange.3307512
Discovery of CDK4-selective molecular glue degraders by high-throughput proteomicsPreprint
Zanon, P. R. A., Shashikadze, B., Winkler, D., Scheller, I. F., Bartoschek, D., Bednarz, A., Graef, T., Machata, S., Ohmayer, U., Schwalb, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.19.733443
Selective CDK2 Degradation via Noncanonical Recruitment
Pei, Y., Lin, W., Li, X., Meng, Y., Yin, Y., Pan, B., Zhou, L., Cao, L., Cang, Y., Jiang, Y., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01264 · Cited by 2
The synthetic landscape of cereblon (CRBN) binders: from thalidomide to emerging chemotypes
Rafael, S., Sánchez, C., Whelan, R., Harris, C., Verdaguer, X., Mayor‐Ruiz, C., & Riéra, A. (2026) · Chemical Society Reviews · doi:10.1039/d6cs00247a · Cited by 2
Liu, Y., Chen, L., Peng, B., Zeng, P., Cao, L., Huang, L., Zhou, L., Yang, S., Wang, J., Sun, Y., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.1973691
Franzini, R. M. (2026) · Molecular Informatics · doi:10.1002/minf.70045
“This trend becomes clearer when separating Cereblon binders, which are partially surface-exposed [37], from other molecular glues that tend to exhibit low accessibility.”
Ubiquitin family as novel protein partners for molecular glues
Silvian, L. F. (2026) · npj Drug Discovery. · doi:10.1038/s44386-026-00059-0
Drugging smart: molecular glue degraders rise in T-ALL
Bornhauser, B. C. (2026) · Blood · doi:10.1182/blood.2026033893
Scalable Extraction of Information on Protein-Protein Interactions using Topological Data AnalysisPreprint
Mukherjee, A., Park, B., Malmstrom, A., Cisewski-Kehe, J., Lehn, R. C. V., & Zavala, V. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743405
Metadata
- Authors
- Petzold, G., Gainza, P., Annunziato, S., Lamberto, I., Trenh, P., McAllister, L. A., DeMarco, B., Schwander, L., Bunker, R. D., Zlotosch, M., SriRamaratnam, R., Gilberto, S., Langousis, G., Donckele, E. J., Quan, C., Strande, V., De Donatis, G. M., Alabi, S. B., Alers, J., Matysik, M., Staehly, C., Dubois, A., Osmont, A., Garskovas, M., Lyon, D., Wiedmer, L., Oleinikovas, V., Lieberherr, R., Rubin, N. T., Lam, D. T., Lucas, X., Liardo, E., Widlund, N. I., Ritzén, A., Caceres, R. M., Vigil, D., Tsai, J., Wallace, O., Peluso, M., Sadok, A., Tiedt, R., Paterson, A. M., Zarayskiy, V., Fasching, B., Bonenfant, D., Warmuth, M., Castle, J. C., & Townson, S. A.
- Affiliations
- Boston Foundation (US)
- Monte Rosa Therapeutics Inc, Boston, MA, USA.
- Corresponding author
- Petzold, Georg
- Castle, John C.
- Townson, Sharon A.
- ORCID
- Petzold, Georg
- Gainza, Pablo
- Annunziato, Stefano
- Trenh, Peter
- McAllister, Laura A.
- Bunker, Richard D.
- SriRamaratnam, Rohitha
- Gilberto, Samuel
- Langousis, Gerasimos
- Donckele, Etienne J.
- Quan, Chao
- Alabi, Shanique B.
- Matysik, Michelle
- Lyon, David
- Oleinikovas, Vladimiras
- Lieberherr, Raphael
- Lucas, Xavier
- Ritzén, Andreas
- Caceres, Ramon Miguel
- Tsai, Jennifer
- Wallace, Owen
- Peluso, Marisa
- Sadok, Amine
- Tiedt, Ralph
- Fasching, Bernhard
- Bonenfant, Debora
- Castle, John C.
- Townson, Sharon A.
- Venue
- Science
- Published
- 2025-07-03
- Volume
- 389
- Issue
- 6755
- Pages
- eadt6736-eadt6736
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4411983851
- Semantic Scholar
- 4bb4e874249f92d431945f892817b0fe43714a19
- Cited by
- 117
- References
- 73
- Citations by year
- 2026: 73 · 2025: 43
- FWCI
- 34.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- molecular glues, Vav1, protein degradation
- MeSH terms
- Humans, Protein Binding, Substrate Specificity, Molecular Mimicry, Amino Acid Motifs, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Data Mining, Drug Repositioning, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.